Divergent effects of 4-1BB antibodies on antitumor immunity and on tumor-reactive T-cell generation.

Kim JA ，Averbook BJ ，Chambers K ，Rothchild K ，Kjaergaard J ，Papay R ，Shu S ... -  《CANCER RESEARCH》

Polarization effects of 4-1BB during CD28 costimulation in generating tumor-reactive T cells for cancer immunotherapy.

Li Q ，Carr A ，Ito F ，Teitz-Tennenbaum S ，Chang AE ... -  《CANCER RESEARCH》

Therapeutic efficacy of OX-40 receptor antibody depends on tumor immunogenicity and anatomic site of tumor growth.

Kjaergaard J ，Tanaka J ，Kim JA ，Rothchild K ，Weinberg A ，Shu S ... -  《CANCER RESEARCH》

Anti-4-1BB monoclonal antibody enhances rejection of large tumor burden by promoting survival but not clonal expansion of tumor-specific CD8+ T cells.

May KF Jr ，Chen L ，Zheng P ，Liu Y ... -  《CANCER RESEARCH》

Augmented antitumor effects of radiation therapy by 4-1BB antibody (BMS-469492) treatment.

Shi W ，Siemann DW 《ANTICANCER RESEARCH》